The use of leukocytes’ secretome to individually target biological therapy in autoimmune arthritis: a case report

The use of leukocytes’ secretome to individually target biological therapy in autoimmune arthritis: a case report

Abstract Background Biological agents have allowed remarkable improvement in controlling autoimmune arthropathies, although none of the numerous biologics readily available represent a universal treatment standard. Moreover, classical and genetic predictors are currently unsatisfactory to predict in...

Full description

Bibliographic Details
Main Authors: Patrice E. Poubelle, Nathalie Pagé, Marie-Pier Longchamps, Natalia Sampaio Moura, David B. Beck, Ivona Aksentijevich, Philippe A. Tessier, Martin Pelletier
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Clinical and Translational Medicine
Subjects:
Biologic agents
Interleukin-6
Personalized medicine
Secretome
Leukocytes
Arthritis
Online Access:http://link.springer.com/article/10.1186/s40169-019-0236-7

Internet

http://link.springer.com/article/10.1186/s40169-019-0236-7

Similar Items